Monitoring and evaluation data from the introduction of DMPA-SC in Nigeria's public and private sectors

Domain:

healthcare

Record type:

dataset

Creator:

Liu

Editor:

Liu

Publisher:

Har

Host:

This dataset contains monitoring data from the pilot introduction of subcutaneous DMPA (DMPA-SC, brand name Sayana® Press) in Nigeria's private and public sectors, from January 1, 2015 through December 31, 2017.

Visit

doi.org dataverse.harvard.edu

Licenses

info:eu-repo/semantics/openAccess Creative Commons Zero v1.0 Universal https://creativecommons.org/publicdomain/zero/1.0/legalcode

Accessing DMPA-SC through the public and private sectors in Nigeria: users’ characteristics and their experiences

Background: Beginning in 2015, subcutaneous depot medroxyprogesterone acetate (

Monitoring data from pilot introductions of DMPA-SC in Burkina Faso, Niger, Senegal and Uganda

This dataset contains monitoring and training data from pilot introduction of subcutaneous DMPA (DMP

Client and provider experiences of DMPA-SC self-injection introduction in select sub-cities in Addis Ababa, Ethiopia

In support of the Ethiopian Ministry of Health’s pilot introduction of the self-injectable contracep

Feasibility and acceptability of self-injected DMPA-SC in Uganda

The purpose of this study was to assess feasibility of subcutaneous depot medroxyprogesterone acetat

Scale-up of the DMPA-SC in Nigeria: Why policy matters توسيع نطاق DMPA - SC في نيجيريا: لماذا السياسة مهمة Mise à l'échelle de la DMPA-SC au Nigéria : pourquoi la politique est importante Ampliación del DMPA-SC en Nigeria: por qué es importante la política

Injectable contraceptives have contributed substantially to Nigeria's rise in modern family planning

Continuation of DMPA-SC or DMPA-IM when administered by community health workers in Uganda

The aim of this study was to examine continuation of subcutaneous and intramuscular depot medroxypro